-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Estrogen, Progestin, and Beyond: Thrombotic Risk and Contraceptive Choices

Program: Education Program
Session: Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, Sickle Cell Disease, Autoimmune disorders, Clinical Research, Thromboembolism, Hemoglobinopathies, Diseases, Immune Disorders, Thrombotic disorders
Monday, December 9, 2024, 2:45 PM-4:00 PM

Leslie Skeith, MD

University of Calgary, Calgary, AB, Canada

Disclosures: Skeith: CSL Behring: Research Funding; Leo Pharma: Honoraria.

See more of: Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
See more of: Education Program
Previous Presentation | Next Presentation >>